ArticleBlood neoplasia2026

Marginal zone lymphoma is associated with dysregulated T-cell immunity that is not altered by ibrutinib-venetoclax treatment.

Joanne E Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.